Clinical Trial Update: Dapagliflozin in Depression [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating dapagliflozin for depression in Phase 1 and Phase 2; recruitment is ongoing at Tanta University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Tanta University | Conditions: Depression | Phase 1, Phase 2 | Status: RECRUITING